Rising global incidence of myeloproliferative diseases boosts demand for specialized treatments. Breakthroughs in JAK inhibitors and thrombopoietin receptor agonists enhance disease management. The push towards personalized medicine and greater research inves…
Zdroj: 📰 GlobeNewswire
| 